ABCA1 and metabolic syndrome: Using both mimics and inhibitors, in keeping with the work of Ramirez et al. [28] and Lucero et al. [27], we confirmed that loss of miR-758-3p (as we observed in MetS) resulted in increased expression of CERP/ABCA1 on the liver cells.